chelsea drug & chemical company limited Company Information
Company Number
00752468
Website
http://genesis-pharma.comRegistered Address
2 leman street, london, E1W 9US
Industry
Manufacture of pharmaceutical preparations
Telephone
02072010400
Next Accounts Due
43 days late
Group Structure
View All
Shareholders
charmian solomon 100%
chelsea drug & chemical company limited Estimated Valuation
Pomanda estimates the enterprise value of CHELSEA DRUG & CHEMICAL COMPANY LIMITED at £0 based on a Turnover of £0 and 1.22x industry multiple (adjusted for size and gross margin).
chelsea drug & chemical company limited Estimated Valuation
Pomanda estimates the enterprise value of CHELSEA DRUG & CHEMICAL COMPANY LIMITED at £0 based on an EBITDA of £0 and a 5.48x industry multiple (adjusted for size and gross margin).
chelsea drug & chemical company limited Estimated Valuation
Pomanda estimates the enterprise value of CHELSEA DRUG & CHEMICAL COMPANY LIMITED at £98.1k based on Net Assets of £39.9k and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Chelsea Drug & Chemical Company Limited Overview
Chelsea Drug & Chemical Company Limited is a live company located in london, E1W 9US with a Companies House number of 00752468. It operates in the manufacture of pharmaceutical preparations sector, SIC Code 21200. Founded in March 1963, it's largest shareholder is charmian solomon with a 100% stake. Chelsea Drug & Chemical Company Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Chelsea Drug & Chemical Company Limited Health Check
Pomanda's financial health check has awarded Chelsea Drug & Chemical Company Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 0 areas for improvement. Company Health Check FAQs
1 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Chelsea Drug & Chemical Company Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Chelsea Drug & Chemical Company Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Chelsea Drug & Chemical Company Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Chelsea Drug & Chemical Company Limited
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Chelsea Drug & Chemical Company Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Chelsea Drug & Chemical Company Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Chelsea Drug & Chemical Company Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Chelsea Drug & Chemical Company Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Chelsea Drug & Chemical Company Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Chelsea Drug & Chemical Company Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Chelsea Drug & Chemical Company Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 20.9%, this is a lower level of debt than the average (42.8%)
- - Chelsea Drug & Chemical Company Limited
- - Industry AVG
CHELSEA DRUG & CHEMICAL COMPANY LIMITED financials
Chelsea Drug & Chemical Company Limited's latest turnover from December 2022 is estimated at 0 and the company has net assets of £39.9 thousand. According to their latest financial statements, we estimate that Chelsea Drug & Chemical Company Limited has no employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Sep 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Cost Of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Admin Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Pre-Tax Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Profit After Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Retained Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Employee Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Number Of Employees | 2 | 2 | 2 | |||||||||||
EBITDA* | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Sep 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total assets | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 | 50,500 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 |
net assets | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 |
total shareholders funds | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 | 39,944 |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Sep 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50,500 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10,556 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||||
interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
cash flow from financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50,500 | ||||||
cash and cash equivalents | ||||||||||||||
cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
chelsea drug & chemical company limited Credit Report and Business Information
Chelsea Drug & Chemical Company Limited Competitor Analysis
Perform a competitor analysis for chelsea drug & chemical company limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mature companies, companies in E1W area or any other competitors across 12 key performance metrics.
chelsea drug & chemical company limited Ownership
CHELSEA DRUG & CHEMICAL COMPANY LIMITED group structure
Chelsea Drug & Chemical Company Limited has 1 subsidiary company.
Ultimate parent company
CHELSEA DRUG & CHEMICAL COMPANY LIMITED
00752468
1 subsidiary
chelsea drug & chemical company limited directors
Chelsea Drug & Chemical Company Limited currently has 2 directors. The longest serving directors include Mrs. Charmian Solomon (Jun 1992) and Mr David Solomon (Jul 2000).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mrs. Charmian Solomon | 88 years | Jun 1992 | - | Director | |
Mr David Solomon | United Kingdom | 54 years | Jul 2000 | - | Director |
P&L
December 2022turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
39.9k
0%
total assets
50.5k
0%
cash
0
0%
net assets
Total assets minus all liabilities
chelsea drug & chemical company limited company details
company number
00752468
Type
Private limited with Share Capital
industry
21200 - Manufacture of pharmaceutical preparations
incorporation date
March 1963
age
61
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2022
previous names
N/A
accountant
-
auditor
-
address
2 leman street, london, E1W 9US
Bank
-
Legal Advisor
-
chelsea drug & chemical company limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to chelsea drug & chemical company limited. Currently there are 1 open charges and 0 have been satisfied in the past.
chelsea drug & chemical company limited Companies House Filings - See Documents
date | description | view/download |
---|